Need help finding what you are looking for?
Contact Us
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1349941
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1349941
Hematopoietic stem cell transplantation market, By Transplant Type, By Indication, By Application, By End User, By Region -Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
PUBLISHED:
PAGES: 208 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global hematopoietic stem cell transplantation (HSCT) market is estimated to be valued at US$ 2.88 Billion in 2023 and is expected to exhibit a CAGR of 11.2% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 2.88 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 11.20% | 2030 Value Projection: | US$ 6.05 Bn |
Hematopoietic cell transplantation (also called bone marrow transplantation or stem cell transplantation) is a type of treatment for cancer (and a few other conditions as well). A review of the normal function of the bone marrow will help in the understanding of stem cell transplantation. Hematopoietic cell transplantation is the most effective treatment for cancer. Other treatments, such as chemotherapy and radiation, are toxic to the bone marrow. In general, the higher the dose, the more toxic the effects on the bone marrow.
There are two main types of hematopoietic cell transplantation: autologous and allogeneic. In autologous transplantation, the patient's own hematopoietic stem cells are removed before high-dose chemotherapy or radiation is given, and they are then frozen for storage and later use. After chemotherapy or radiation is complete, the harvested cells are thawed and returned to the patient. In allogeneic transplantation, the hematopoietic stem cells come from a donor, ideally a brother or sister with a similar genetic makeup.
Market Dynamics
The increasing organic growth strategies, such as product launches by key market players to expand their product portfolio are expected to drive market growth over the forecast period. For instance, in January 2020, Bluebird Bio, Inc., a company providing gene therapy products, announced the launch of ZYNTEGLO (autologous CD34+ cells encoding βA-T87Q-globin gene), a one-time gene therapy for patients 12 years of age and older with transfusion-dependent β-thalassemia (TDT) for hematopoietic stem cell (HSC) transplantation in Germany. The full common name for ZYNTEGLO is a genetically modified autologous CD34+ cell-enriched population that contains hematopoietic stem cells transduced with a lentiviral vector encoding the βA-T87Q-globin gene.
Key features of the study:
- This report provides an in-depth analysis of the global hematopoietic stem cell transplantation (HSCT) market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global hematopoietic stem cell transplantation (HSCT) market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Inc., Talaris Therapeutics, Inc., Marker Therapeutics Inc., Stempeutics Research Pvt Ltd., CBR Systems Inc., Priothera Ltd., Eurobio Scientific Group, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Sanofi, FUJIFILM Holdings Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global hematopoietic stem cell transplantation (HSCT) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hematopoietic stem cell transplantation (HSCT) market
Detailed Segmentation:
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market , By Transplant Type:
- Allogeneic
- Autologous
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Indication:
- Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
- Hodgkin lymphoma (HL)
- Non-Hodgkin Lymphoma (NHL)
- Multiple Myeloma (MM)
- Others
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application:
- Bone Marrow Transplant (BMT)
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Cord Blood Transplant (CBT)
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By End User:
- Hospitals
- Specialty Clinics
- Others
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Pluristem Therapeutics Inc.
- CellGenix GmbH
- Regen Biopharma Inc.
- Lonza Group
- Kiadis Pharma
- Taiga Biotechnologies, Inc.
- Takeda Pharmaceutical Company Limited
- Escape Therapeutics, Inc.
- Bluebird Bio, Inc.
- Talaris Therapeutics, Inc.
- Marker Therapeutics Inc.
- Stempeutics Research Pvt Ltd.
- CBR Systems Inc.
- Priothera Ltd.
- Eurobio Scientific Group
- Otsuka America Pharmaceutical, Inc.
- Pfizer Inc.
- Sanofi
- FUJIFILM Holdings Corporation
Product Code: CMI1250
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Transplant Type
- Market Snippet, By Indication
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Hematopoietic Stem Cell Transplantation (HSCT) Market- COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Transplant Type, 2018- 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
6. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Indication, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Acute Myeloid Leukemia (AML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Acute Lymphoblastic Leukemia (ALL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Hodgkin lymphoma (HL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Non-Hodgkin Lymphoma (NHL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Multiple Myeloma (MM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
7. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Bone Marrow Transplant (BMT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Cord Blood Transplant (CBT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
8. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By End User, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018- 2030, (US$ Bn)
9. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Region, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Pluristem Therapeutics Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CellGenix GmbH
- Regen Biopharma Inc.
- Lonza Group
- Kiadis Pharma
- Taiga Biotechnologies, Inc.
- Takeda Pharmaceutical Company Limited
- Escape Therapeutics, Inc.
- Bluebird Bio,Inc.
- Talaris Therapeutics, Inc.,
- Marker Therapeutics Inc.
- Stempeutics Research Pvt Ltd.
- CBR Systems Inc.
- Priothera Ltd.
- Eurobio Scientific Group
- Otsuka America Pharmaceutical, Inc.
- Pfizer Inc.
- Sanofi
- FUJIFILM Holdings Corporation
11. Section
- References
- Research Methodology
- About us and Sales Contact
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.